open label safety study

Medivation and Astellas Pharma Have Announced FDA Approval
Dec 14, 2012
Medivation and Astellas Pharma have announced FDA approval for Xtandi (enzalutamide) capsules to treat metastatic castration-resistant prostate cancer in patients with previously received docetaxel. Medivation and Astellas expect to make ...

Tags: Medivation, Astellas, FDA
Insmed Has Dosed First Cystic Fibrosis (CF) Patient in The Clinical Evaluation
Nov 28, 2012
Insmed has dosed first Cystic Fibrosis (CF) patient in the Clinical Evaluation of ARIKACE (CLEAR-108) phase 3 study of Arikace (liposomal amikacin for inhalation) in Europe. CLEAR-108 is a 300-patient randomized phase 3 trial comparing ...

Tags: Study of Arikace, pulmonary function, open-label safety study
BioDelivery Designed as a Treatment for Moderate to Severe Chronic Pain.
Nov 28, 2012
BioDelivery Sciences International, a developer of drug delivery technologies, and Endo Health Solutions have started enrolling patients for its Phase 3 clinical program of BEMA Buprenorphine, designed as a treatment for moderate to severe ...

Tags: BioDelivery Sciences International, Endo Health Solutions